Roche Holding AG (0QOK.IL)
Develops medicines for cancer, infections, and immune diseases, plus tests that diagnose illnesses.
323.90+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+24.4%
The outlook
Roche is trading below both its 50- and 200-day moving averages, suggesting recent downward pressure. The stock sits two-thirds of the way up its 52-week range, with analyst sentiment leaning bearish overall. At a trailing P/E of 24.9, the valuation remains elevated relative to the broader market backdrop.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range66% of the way from its 52-week low to high
Market cap
$274.85B
52-wk high
377.00
52-wk low
221.30
50-day avg
323.99
200-day avg
324.16
Trailing P/E
24.9